Info@accuref.com
1-866-497-4180 (U.S Toll Free)
1-408-773-8007
Accuref logo s

Onco-Ref™ FFPE Cell Scroll Reference Standard TP53 c.473G>T p.R158L COSM10714


Description:

The Onco-Ref™ FFPE Cell Scroll is a biologically-relevant molecular reference standard that can be directly incorporated into your sample processing workflows to optimize protocols, evaluate assay sensitivity and specificity, and analyze the impact of workflow changes on downstream analysis.


Datasheet MSDS

Certificate of Analysis
E6192S201336

Variant Information:
Mutation Id: COSM10714 View in COSMIC Database
Gene: TP53
Nucleotide Change: c.473G>T
Amino Acid Change: p.R158L
Frequency: Heterozygous
General Information:
Catalog ASE-6192S
Size 1 scroll
Format FFPE
Volume/Dimension 20 µm section with a 7.0 mm diameter cell pellet core
Quantity n/a
Concentration > 400 ng /scroll
Cell(s) HCT116
Shelf Life 36 months
Shipping Temperature Ambient
Fixation Process 10% buffered formalin solution (4% formaldehyde); 24 hrs; room temperature
Storage Temperature -20°C
Quality Control Genotype: Sanger sequencing of locus-specific PCR (cell line)
Quality: > 60% cell density (H&E staining of 5µm cell slide)
Manufacturing: ISO 9001:2015 and ISO 13485:2016 Certified
Regulatory Research Use Only. Not Intended for human or animal diagnostic or therapeutic use.
Restrictions This is a limited use product. This product, any material that contains this product in whole or in part, any progeny, modification or derivative of this product, any cell or animal made or modified by using this product, and any progeny, modification or derivative of such cell or animal may not be transferred by the purchaser to any other person, entity or any of the above to perform services for the benefit of any other person or entity or for commercial purpose of any kind. This product may only be used by the purchaser for its internal research for use as a research tool for research purposes.
Ase 6192s
(Click Image To Enlarge)

Catalog: ASE-6192S
© 2019 Copyright AccuRef Diagnostics, a Division of Applied StemCell Inc.